• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Margaret R Markman, K A Iseminger, Kenneth D. Hatch, William t. Creasman, Willard A. Barnes, Brent Dubeshter
  • Medicine
  • Gynecologic oncology
  • 1996 (First Publication: 1 July 1996)
  • There is a critical need to find additional effective therapies in the management of ovarian cancer. A previously reported Gynecologic Oncology Group trial demonstrated that tamoxifen is an activeExpand
  • Kenneth D. Hatch, Jackson B. Beecham, John A. Blessing, William t. Creasman
  • Medicine
  • Cancer
  • 1991 (First Publication: 15 July 1991)
  • One hundred five patients with Stage III or IV epithelial ovarian cancer whose disease had persisted or recurred after primary surgery and first-line chemotherapy were given tamoxifen (20 mg orallyExpand
  • Hugh M. Shingleton, Seng-jaw Soong, Mark S. Gelder, Kenneth D. Hatch, Vicki V. Baker, Maxwell J. Austin
  • Medicine
  • Obstetrics and gynecology
  • 1989 (First Publication: 1 June 1989)
  • &NA; Between September 1969 and January 1, 1986, 143 pelvic exenterations for recurrent cervical cancer were performed by the gynecologic oncologists at the University of Alabama at Birmingham. OfExpand
  • Setsuko K. Chambers, Mary C. Clouser, +12 authors David S. Alberts
  • Medicine
  • Clinical Cancer Research
  • 2010 (First Publication: 12 October 2010)
  • Purpose: This phase II trial evaluated bevacizumab plus erlotinib in platinum-resistant ovarian cancer; exploratory biomarker analyses, including that of tumor vascular endothelial growth factor AExpand
  • James F. Barter, Seng Jaw Soong, Hugh M. Shingleton, Kenneth D. Hatch, James Wilder Orr
  • Medicine
  • Gynecologic oncology
  • 1989 (First Publication: 1 March 1989)
  • Fifty patients with cervical cancer were treated with radical hysterectomy and lymphadenectomy followed by postoperative radiation therapy for high risk factors (nodal metastases, lymphvascular spaceExpand